Brazil’s ‘Milestone’ Clinical Research Decree Expected To Double Clinical Trials

 
• By Francesca Bruce
  
Brazilian authorities hope that a new decree will help the country climb into the top ten clinical research markets. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from R&D

More from Pink Sheet